000 -LEADER |
fixed length control field |
02053cam a2200517 i 4500 |
001 - CONTROL NUMBER |
control field |
18351360 |
005 - DATE AND TIME OF LATEST TRANSACTION |
control field |
20180301101903.0 |
008 - FIXED-LENGTH DATA ELEMENTS--GENERAL INFORMATION |
fixed length control field |
141028s2014 enka b 001 0 eng c |
010 ## - LIBRARY OF CONGRESS CONTROL NUMBER |
LC control number |
2014451468 |
020 ## - INTERNATIONAL STANDARD BOOK NUMBER |
International Standard Book Number |
9781849738064 (hbk.) |
020 ## - INTERNATIONAL STANDARD BOOK NUMBER |
International Standard Book Number |
1849738068 (hbk.) |
020 ## - INTERNATIONAL STANDARD BOOK NUMBER |
Canceled/invalid ISBN |
9781782624202 (PDF) |
035 ## - SYSTEM CONTROL NUMBER |
System control number |
(OCoLC)ocn872426059 |
040 ## - Cataloging Source |
Transcribing Agency |
TUM |
050 00 - LIBRARY OF CONGRESS CALL NUMBER |
Classification number |
RS420 |
Item number |
.O77 2014 |
245 00 - TITLE STATEMENT |
Title |
Orphan drugs and rare diseases / |
Statement of responsibility, etc. |
edited by David C. Pryde, Pfizer Global Research and Development, Cambridge, UK, Michael J. Palmer, Medicinal Chemistry Consultant, UK. |
260 ## - PUBLICATION, DISTRIBUTION, ETC. (IMPRINT) |
Place of publication, distribution, etc. |
Cambridge |
Name of publisher, distributor, etc. |
Royal Society of Chemistry |
Date of publication, distribution, etc. |
2014 |
300 ## - PHYSICAL DESCRIPTION |
Extent |
xxii, 463 pages : |
Other physical details |
illustrations (some color) ; |
Dimensions |
24 cm. |
504 ## - BIBLIOGRAPHY, ETC. NOTE |
Bibliography, etc |
Includes bibliographical references and index. |
650 #0 - SUBJECT ADDED ENTRY--TOPICAL TERM |
Topical term or geographic name as entry element |
Orphan drugs. |
650 #0 - SUBJECT ADDED ENTRY--TOPICAL TERM |
Topical term or geographic name as entry element |
Drug development. |
650 #0 - SUBJECT ADDED ENTRY--TOPICAL TERM |
Topical term or geographic name as entry element |
Rare diseases. |
650 12 - SUBJECT ADDED ENTRY--TOPICAL TERM |
Topical term or geographic name as entry element |
Rare Diseases |
General subdivision |
drug therapy. |
650 22 - SUBJECT ADDED ENTRY--TOPICAL TERM |
Topical term or geographic name as entry element |
Orphan Drug Production. |
650 #7 - SUBJECT ADDED ENTRY--TOPICAL TERM |
Topical term or geographic name as entry element |
Drug development. |
Source of heading or term |
fast |
650 #7 - SUBJECT ADDED ENTRY--TOPICAL TERM |
Topical term or geographic name as entry element |
Orphan drugs. |
Source of heading or term |
fast |
650 #7 - SUBJECT ADDED ENTRY--TOPICAL TERM |
Topical term or geographic name as entry element |
Rare diseases. |
Source of heading or term |
fast |
650 #7 - SUBJECT ADDED ENTRY--TOPICAL TERM |
Topical term or geographic name as entry element |
Médicaments orphelins. |
Source of heading or term |
ram |
700 1# - ADDED ENTRY--PERSONAL NAME |
Personal name |
Pryde, David C., |
Relator term |
editor. |
700 1# - ADDED ENTRY--PERSONAL NAME |
Personal name |
Palmer, Michael J., |
Relator term |
editor. |
710 2# - ADDED ENTRY--CORPORATE NAME |
Corporate name or jurisdiction name as entry element |
Royal Society of Chemistry (Great Britain), |
Relator term |
issuing body. |
942 ## - ADDED ENTRY ELEMENTS (KOHA) |
Source of classification or shelving scheme |
|
Koha item type |
Books |